Beasley R, Roche W, Holgate S T
Medicine 1 and Pathology, Southampton General Hospital, United Kingdom.
Drugs. 1989;37 Suppl 1:117-22; discussion 127-36. doi: 10.2165/00003495-198900371-00021.
Bronchial asthma is an inflammatory disease. The characteristic pathological features of epithelial cell loss, goblet cell hyperplasia, increased deposition of collagen beneath the basement membrane, mast cell degranulation, and inflammatory cell infiltration of the mucosa are not limited to fatal asthma. Similar inflammatory events have been observed in subjects who would be considered to have clinically stable asthma. These observations would suggest that pharmacological treatment directed against the underlying inflammatory processes in asthma should not be limited to those patients with severe forms of the disease.
支气管哮喘是一种炎症性疾病。上皮细胞丧失、杯状细胞增生、基底膜下胶原蛋白沉积增加、肥大细胞脱颗粒以及黏膜炎症细胞浸润等特征性病理表现并不局限于致死性哮喘。在被认为临床哮喘病情稳定的患者中也观察到了类似的炎症事件。这些观察结果表明,针对哮喘潜在炎症过程的药物治疗不应仅限于患有严重形式疾病的患者。